Anne Wojcicki's nonprofit, TTAM Research Institute, will acquire 23andMe for $305 million, following a bankruptcy filing and bidding war. The deal, approved by a US bankruptcy judge, includes 23andMe's genetic testing service, research operations, and telehealth subsidiary. While Wojcicki stepped down as CEO before the bankruptcy, her nonprofit's acquisition ensures 23andMe's continuation. However, several states, including California, oppose the sale due to concerns about customer data privacy and compliance with state laws. 23andMe assures customers their data will be protected and they can opt out of research.

Prepared by Christopher Adams and reviewed by editorial team.